|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.67 USD | -12.17% |
|
+11.72% | -60.36% |
Sept 12 (Reuters) - Eiger BioPharmaceuticals Inc said on Tuesday it would discontinue a late-stage study testing its experimental drug to treat the most severe form of viral hepatitis. (Reporting by Mariam Sunny in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| -60.36% | 3.95M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
EIGER BIOPHARMACEUTICALS, INC. 
